Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04568889 · ClinicalTrials.gov registry record · NA

Minnesota COVID-19 Testing Project

A NA study of COVID-19 and Infectious Disease, sponsored by Harvard University.

Completed
Registry status
NA
Development phase
561
Enrollment target
10
Study locations

NCT04568889: Completed NA study of COVID-19 and Infectious Disease, sponsored by Harvard University.

NCT04568889 is a NA study of COVID-19 and Infectious Disease that has completed, run by Harvard University. The registered enrollment target is 561 participants, below the 38,463-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 10 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04568889, a NA study of COVID-19 and Infectious Disease, has completed, sponsored by Harvard University.

COMPLETED
Registry status
NA
Development phase
561 participants
Enrollment target
10
Study locations

Study Summary

The goal of this project is to help the state of Minnesota understand why individuals are not getting tested and potentially identify trusted individuals or organizations that could be used in follow-up work to send messages. Investigators focus on the first two issues of unit and item nonresponse, which is not random across the population and thus could lead to nonresponse bias. To do so, investigators are deploying flyers through 10 Twin City area food shelves and potentially through public housing units with information on how to answer an online questionnaire.

Primary Outcome

Number of participants who received a flyer that mentions a $20 incentive and completed the survey

Interventions

  • BEHAVIORAL A $10 Survey Incentive
  • BEHAVIORAL A $20 Survey Incentive
  • BEHAVIORAL Emphasis of Government Involvement
  • BEHAVIORAL Emphasis of Academic Researchers Involvement
  • BEHAVIORAL Cost-Benefit Frame

Study Locations (10)

Minnesota

  • Volunteers Enlisted to Assist People - Bloomington
  • Southern Anoka Community Assistance - Columbia Heights
  • People Reaching Out to People Food Shelf - Eden Prairie
  • Fridley Covenant Church - Fridley
  • Calvary Lutheran Church Food Shelf - Minneapolis
  • NorthPoint Health and Wellness - Minneapolis
  • Community Emergency Assistance Programs - Minneapolis
  • Intercongregation Communities Association - Minnetonka
  • Valley Outreach - Stillwater
  • White Bear Area Foodshelf - White Bear Lake

Trial Details

FieldValue
Enrollment Target 561 participants
Start Date 2020-09-28
Est. Completion 2022-08-31
Phase NA
Harvard University

37 total trials

What the finished NCT04568889 record still lists

NCT04568889 is an interventional study that assigns participants to a tested intervention. The registered 561 participants enrollment target is mid-sized for trials with a published cap, below the 38,463-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 5 interventions - of which A $10 Survey Incentive is the first listed.

NCT04568889 lists 10 locations in 1 state (Minnesota).

Frequently Asked Questions

What is clinical trial NCT04568889 about?

NCT04568889 is a clinical study titled "Minnesota COVID-19 Testing Project". The goal of this project is to help the state of Minnesota understand why individuals are not getting tested and potentially identify trusted individuals or organizations that could be used in follow-up work to send messages. Investigators focus on the first two issues of unit and item nonresponse, ...

What is the current status of trial NCT04568889?

This trial is currently completed. It is a NA study. The enrollment target is 561 participants. The study started on 2020-09-28. Estimated completion is 2022-08-31.

What conditions does trial NCT04568889 study?

This clinical trial studies the following conditions: COVID-19, Infectious Disease.

What interventions are being tested in trial NCT04568889?

The interventions under investigation include: A $10 Survey Incentive (BEHAVIORAL), A $20 Survey Incentive (BEHAVIORAL), Emphasis of Government Involvement (BEHAVIORAL), Emphasis of Academic Researchers Involvement (BEHAVIORAL), Cost-Benefit Frame (BEHAVIORAL).

Who is sponsoring clinical trial NCT04568889?

This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04568889 being conducted?

This trial has 10 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04568889's enrollment target sits among peer trials

561 103rd of 298 higher than 196 of 298 other COVID-19 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07007065 · 561 participants · Phase 3

    Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  • NCT04661358 · 560 participants · Phase 3

    Fenofibrate for Prevention of DR Worsening

  • NCT05473871 · 560 participants · NA

    Enhancing Capacity in Churches to Implement PA Programs

  • NCT06001541 · 560 participants · NA

    Web-based Program to Improve Self-management Among Veterans-caregiver Dyads

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04568889, the US trial registry maintained by the National Library of Medicine. NCT04568889 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.